These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6788)

  • 1. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmitter mobilization at the frog neuromuscular junction.
    Alkadhi K; Volle RL
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):261-75. PubMed ID: 23083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of calcium ions on bimodal parameters of mediator liberation in frog sartorius muscle neuromuscular junctions].
    Zefirov AL
    Fiziol Zh SSSR Im I M Sechenova; 1980 Apr; 66(4):531-6. PubMed ID: 6104608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual action of ouabain on transmitter release at neuromuscular junctions of the frog.
    Brănişteanu DD; Proca B; Haulică ID
    J Pharmacol Exp Ther; 1979 Apr; 209(1):31-6. PubMed ID: 34716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of lead on neuromuscular junctions.
    Atchison WD; Narahashi T
    Neurotoxicology; 1984; 5(3):267-82. PubMed ID: 6097847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 4-aminopyridine at the frog neuromuscular junction.
    Molgo J; Lemeignan M; Lechat P
    J Pharmacol Exp Ther; 1977 Dec; 203(3):653-63. PubMed ID: 21957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and amplitude gradients of spontaneous release along the length of the frog neuromuscular junction.
    Robitaille R; Tremblay JP
    Synapse; 1989; 3(4):291-307. PubMed ID: 2568018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals.
    Lundh H; Thesleff S
    Eur J Pharmacol; 1977 Apr; 42(4):411-2. PubMed ID: 15849
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG; Lundh H; Thesleff S
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Binomial parameters of mediator release in the process of facilitation of neuromuscular transmission].
    Zefirov AL
    Neirofiziologiia; 1980; 12(3):314-6. PubMed ID: 6105625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of calcium ions in stannous chloride-induced facilitation of transmitter release from frog motor nerve terminals.
    Hattori T; Maehashi H
    Res Commun Chem Pathol Pharmacol; 1990 May; 68(2):267-70. PubMed ID: 1972290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between temperature and calcium ion concentration in the medium and the effect of imidazole, guanidine and theophylline on mediator release at the frog neuromuscular synapse].
    Gotgil'f IM
    Neirofiziologiia; 1977; 9(4):430-6. PubMed ID: 302923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of evoked synaptic release in rat neuromuscular junction.
    Di Gregorio F; Cereser S; Favaro G; Fiori MG
    J Peripher Nerv Syst; 1996; 1(1):65-72. PubMed ID: 10970121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1982 Jul; 222(1):87-93. PubMed ID: 6123595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lindane upon transmitter release and end-plate responsiveness in the neuromuscular junction of the frog.
    Joy RM; Vogel SM; Narahashi T
    Neuropharmacology; 1987 Aug; 26(8):1223-9. PubMed ID: 2443872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.
    Miyamoto MD
    J Physiol; 1975 Aug; 250(1):121-42. PubMed ID: 240928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein phosphatase inhibitor okadaic acid enhances transmitter release at neuromuscular junctions.
    Abdul-Ghani M; Kravitz EA; Meiri H; Rahamimoff R
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1803-7. PubMed ID: 1672044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.